Cenlub Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 11:00 am

Competitors of Cenlub Industries Ltd

All Competitor Stocks of Cenlub Industries Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:34 am

Below is a detailed analysis of the quarterly data for Cenlub Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 20.68 Cr.. The value appears strong and on an upward trend. It has increased from 16.71 Cr. (Dec 2024) to 20.68 Cr., marking an increase of 3.97 Cr..
• For Expenses, as of Mar 2025, the value is 17.18 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.42 Cr. (Dec 2024) to 17.18 Cr., marking an increase of 2.76 Cr..
• For Operating Profit, as of Mar 2025, the value is 3.50 Cr.. The value appears strong and on an upward trend. It has increased from 2.29 Cr. (Dec 2024) to 3.50 Cr., marking an increase of 1.21 Cr..
• For OPM %, as of Mar 2025, the value is 16.92%. The value appears strong and on an upward trend. It has increased from 13.70% (Dec 2024) to 16.92%, marking an increase of 3.22%.
• For Other Income, as of Mar 2025, the value is 0.96 Cr.. The value appears strong and on an upward trend. It has increased from 0.65 Cr. (Dec 2024) to 0.96 Cr., marking an increase of 0.31 Cr..
• For Interest, as of Mar 2025, the value is 0.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.16 Cr. (Dec 2024) to 0.11 Cr., marking a decrease of 0.05 Cr..
• For Depreciation, as of Mar 2025, the value is 0.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.20 Cr. (Dec 2024) to 0.28 Cr., marking an increase of 0.08 Cr..
• For Profit before tax, as of Mar 2025, the value is 4.07 Cr.. The value appears strong and on an upward trend. It has increased from 2.58 Cr. (Dec 2024) to 4.07 Cr., marking an increase of 1.49 Cr..
• For Tax %, as of Mar 2025, the value is 35.38%. The value appears to be increasing, which may not be favorable. It has increased from 25.19% (Dec 2024) to 35.38%, marking an increase of 10.19%.
• For Net Profit, as of Mar 2025, the value is 2.64 Cr.. The value appears strong and on an upward trend. It has increased from 1.94 Cr. (Dec 2024) to 2.64 Cr., marking an increase of 0.70 Cr..
• For EPS in Rs, as of Mar 2025, the value is 5.66. The value appears strong and on an upward trend. It has increased from 4.16 (Dec 2024) to 5.66, marking an increase of 1.50.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:41 am

Growth

Last Updated: September 5, 2025, 2:51 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Cenlub Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 17, the value is 4.24. This value is below the healthy minimum of 5. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
• For Diluted EPS (Rs.), as of Mar 17, the value is 4.24. This value is below the healthy minimum of 5. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
• For Cash EPS (Rs.), as of Mar 17, the value is 5.99. This value is within the healthy range. It has increased from 3.77 (Mar 16) to 5.99, marking an increase of 2.22.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 43.29. It has increased from 39.05 (Mar 16) to 43.29, marking an increase of 4.24.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 43.29. It has increased from 39.05 (Mar 16) to 43.29, marking an increase of 4.24.
• For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 86.25. It has increased from 76.07 (Mar 16) to 86.25, marking an increase of 10.18.
• For PBDIT / Share (Rs.), as of Mar 17, the value is 13.05. This value is within the healthy range. It has increased from 10.30 (Mar 16) to 13.05, marking an increase of 2.75.
• For PBIT / Share (Rs.), as of Mar 17, the value is 11.30. This value is within the healthy range. It has increased from 8.97 (Mar 16) to 11.30, marking an increase of 2.33.
• For PBT / Share (Rs.), as of Mar 17, the value is 6.90. This value is within the healthy range. It has increased from 3.73 (Mar 16) to 6.90, marking an increase of 3.17.
• For Net Profit / Share (Rs.), as of Mar 17, the value is 4.24. This value is within the healthy range. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
• For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 4.24. This value is within the healthy range. It has increased from 2.44 (Mar 16) to 4.24, marking an increase of 1.80.
• For PBDIT Margin (%), as of Mar 17, the value is 15.13. This value is within the healthy range. It has increased from 13.54 (Mar 16) to 15.13, marking an increase of 1.59.
• For PBIT Margin (%), as of Mar 17, the value is 13.10. This value is within the healthy range. It has increased from 11.79 (Mar 16) to 13.10, marking an increase of 1.31.
• For PBT Margin (%), as of Mar 17, the value is 7.99. This value is below the healthy minimum of 10. It has increased from 4.90 (Mar 16) to 7.99, marking an increase of 3.09.
• For Net Profit Margin (%), as of Mar 17, the value is 4.92. This value is below the healthy minimum of 5. It has increased from 3.20 (Mar 16) to 4.92, marking an increase of 1.72.
• For NP After MI And SOA Margin (%), as of Mar 17, the value is 4.92. This value is below the healthy minimum of 8. It has increased from 3.20 (Mar 16) to 4.92, marking an increase of 1.72.
• For Return on Networth / Equity (%), as of Mar 17, the value is 9.80. This value is below the healthy minimum of 15. It has increased from 6.24 (Mar 16) to 9.80, marking an increase of 3.56.
• For Return on Capital Employeed (%), as of Mar 17, the value is 18.04. This value is within the healthy range. It has increased from 14.61 (Mar 16) to 18.04, marking an increase of 3.43.
• For Return On Assets (%), as of Mar 17, the value is 3.94. This value is below the healthy minimum of 5. It has increased from 2.34 (Mar 16) to 3.94, marking an increase of 1.60.
• For Long Term Debt / Equity (X), as of Mar 17, the value is 0.38. This value is within the healthy range. It has decreased from 0.49 (Mar 16) to 0.38, marking a decrease of 0.11.
• For Total Debt / Equity (X), as of Mar 17, the value is 0.90. This value is within the healthy range. It has decreased from 1.07 (Mar 16) to 0.90, marking a decrease of 0.17.
• For Asset Turnover Ratio (%), as of Mar 17, the value is 0.79. It has decreased from 0.83 (Mar 16) to 0.79, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 17, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.29 (Mar 16) to 1.32, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 17, the value is 1.05. This value is within the healthy range. It has increased from 0.94 (Mar 16) to 1.05, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 17, the value is 3.14. This value is below the healthy minimum of 4. It has decreased from 3.16 (Mar 16) to 3.14, marking a decrease of 0.02.
• For Interest Coverage Ratio (X), as of Mar 17, the value is 2.97. This value is below the healthy minimum of 3. It has increased from 1.97 (Mar 16) to 2.97, marking an increase of 1.00.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 1.96. This value is below the healthy minimum of 3. It has increased from 1.47 (Mar 16) to 1.96, marking an increase of 0.49.
• For Enterprise Value (Cr.), as of Mar 17, the value is 32.07. It has increased from 17.74 (Mar 16) to 32.07, marking an increase of 14.33.
• For EV / Net Operating Revenue (X), as of Mar 17, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 16) to 0.90, marking an increase of 0.34.
• For EV / EBITDA (X), as of Mar 17, the value is 5.96. This value is within the healthy range. It has increased from 4.18 (Mar 16) to 5.96, marking an increase of 1.78.
• For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 16) to 0.68, marking an increase of 0.44.
• For Price / BV (X), as of Mar 17, the value is 1.36. This value is within the healthy range. It has increased from 0.48 (Mar 16) to 1.36, marking an increase of 0.88.
• For Price / Net Operating Revenue (X), as of Mar 17, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 16) to 0.68, marking an increase of 0.44.
• For EarningsYield, as of Mar 17, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 16) to 0.07, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness